DMEM, or Opti-MEM, that is the Question: An Important Consideration for Extracellular Vesicle Isolation and their Downstream Applications

preprint OA: closed
⚙ AI-generated deep summary by claude@2026-07, 2026-07-03 · read from full text ⓘ

The paper compares extracellular vesicle (EV) production and properties from MDA-MB-231 or HEK-293T cells cultured in EV-depleted DMEM versus Opti-MEM, a serum-free synthetic medium. Cells in Opti-MEM released significantly more CD9- and CD63-positive EVs, with proteomics showing EVs in EV-DEP DMEM containing higher levels of histones and bovine proteins, and Opti-MEM producing a higher proportion of small EVs from the sphingomyelinase-MVB pathway. In contrast, EV-DEP DMEM relied more on the ROCK pathway for ectosome release and involved RabGTPase-dependent mechanisms (Rab3d, Rab27a, Rab27b) for MVB-derived EV release, whereas Opti-MEM did not. A stated caveat is that the study emphasizes medium-dependent differences in EV biogenesis and composition, which can complicate downstream applications, especially for therapeutic or immunological experiments, and it notes an abstract resubmission issue not fully updated to match added data. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Serum-free synthetic media are frequently used as an alternative to extracellular vesicle-depleted serum containing media (EV-DEP) for EV production. However, the impact of this medium on EV biogenesis, release, and composition remains poorly understood. Here, we comprehensively characterised EV release by MDA-MB-231 or HEK-293T cells cultured in EV-DEP DMEM versus a serum-free synthetic medium, Opti-MEM. In Opti-MEM culture, cells released significantly more CD9- and CD63-positive EVs compared to EV-DEP DMEM. Proteomic analysis revealed that EVs from EV-DEP DMEM contained more histones and bovine proteins. Cells cultured in Opti-MEM released a substantially higher proportion of small-EVs derived from the sphingomyelinase-MVB pathway (60%) compared to EV-DEP DMEM (30%). Conversely, cells cultured in EV-DEP DMEM were more reliant upon the ROCK kinase pathway to release ectosomes (45 %) compared to OptiMEM (15 %). Where cells cultured in EV-DEP DMEM employed RabGTPase-dependent mechanisms for MVB-derived EV release (Rab3d, Rab27a, and Rab27b), cells cultured in Opti-MEM did not. Given that cells cultured in Opti-MEM vs EV-DEP DMEM produce EVs with different protein signatures from distinct molecular pathways, the choice of medium should be carefully considered when designing EV studies – particularly if they are to be used in therapeutic or immunological experiments.
Full text 1,631 characters · extracted from oa-doi-fallback · click to expand
Abstract Serum-free synthetic media are frequently used as an alternative to extracellular vesicle-depleted serum containing media (EV-DEP) for EV production. However, the impact of this medium on EV biogenesis, release, and composition remains poorly understood. Here, we comprehensively characterised EV release by MDA-MB-231 or HEK-293T cells cultured in EV-DEP DMEM versus a serum-free synthetic medium, Opti-MEM. In Opti-MEM culture, cells released significantly more CD9- and CD63-positive EVs compared to EV-DEP DMEM. Proteomic analysis revealed that EVs from EV-DEP DMEM contained more histones and bovine proteins. Cells cultured in Opti-MEM released a substantially higher proportion of small-EVs derived from the sphingomyelinase-MVB pathway (60%) compared to EV-DEP DMEM (30%). Conversely, cells cultured in EV-DEP DMEM were more reliant upon the ROCK kinase pathway to release ectosomes (45 %) compared to OptiMEM (15 %). Where cells cultured in EV-DEP DMEM employed RabGTPase-dependent mechanisms for MVB-derived EV release (Rab3d, Rab27a, and Rab27b), cells cultured in Opti-MEM did not. Given that cells cultured in Opti-MEM vs EV-DEP DMEM produce EVs with different protein signatures from distinct molecular pathways, the choice of medium should be carefully considered when designing EV studies - particularly if they are to be used in therapeutic or immunological experiments. Competing Interest Statement The authors have declared no competing interest. Footnotes The abstract was not amended on the last resubmission to reflect the new data. The abstract now reads to inform on the new data in figure 4 and 5.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00